- Stocks
- Healthcare
- NASDAQ: AXNX

Price (delayed)

$51.70

Market cap

$2.06B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.96

Enterprise value

$1.82B

AXNX's gross profit has surged by 72% since the previous quarter

The revenue has surged by 64% since the previous quarter

AXNX's quick ratio is down by 25% since the previous quarter but it is up by 12% year-on-year

The company's debt rose by 25% YoY

What are the main financial stats of AXNX

Market
Valuations
Earnings

Shares outstanding

39.81M

Market cap

$2.06B

Enterprise value

$1.82B

Price to earnings (P/E)

N/A

Price to book (P/B)

6.95

Price to sales (P/S)

23.16

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

20.99

Revenue

$86.7M

EBIT

-$64.33M

EBITDA

-$62.76M

Free cash flow

-$85.86M

Per share
Balance sheet
Liquidity

EPS

-$1.96

Free cash flow per share

-$2.21

Book value per share

$7.44

Revenue per share

$2.23

TBVPS

$8.95

Total assets

$347.67M

Total liabilities

$53.77M

Debt

$30.87M

Equity

$293.9M

Working capital

$295.64M

Debt to equity

0.11

Current ratio

8.62

Quick ratio

7.39

Net debt/EBITDA

3.8

Margins
Efficiency
Dividend

EBITDA margin

-72.4%

Gross margin

58.1%

Net margin

-76.5%

Operating margin

-75.6%

Return on assets

-23.4%

Return on equity

-28%

Return on invested capital

-98.5%

Return on capital employed

-20.8%

Return on sales

-74.2%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Axonics Modulation Technologies stock price performed over time

Intraday

-1.99%

1 week

-0.25%

1 month

17.79%

1 year

69.84%

YTD

3.57%

QTD

3.57%

How have Axonics Modulation Technologies's revenue and profit performed over time

Revenue

$86.7M

Gross profit

$50.37M

Operating income

-$65.54M

Net income

-$66.32M

Gross margin

58.1%

Net margin

-76.5%

The operating margin has surged by 95% year-on-year and by 51% since the previous quarter

The company's net margin has surged by 95% YoY and by 51% QoQ

AXNX's gross profit has surged by 72% since the previous quarter

The revenue has surged by 64% since the previous quarter

What is Axonics Modulation Technologies's growth rate over time

What is Axonics Modulation Technologies stock price valuation

P/E

N/A

P/B

6.95

P/S

23.16

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

20.99

AXNX's EPS is up by 25% since the previous quarter

The P/B is 36% above the last 4 quarters average of 5.1

The revenue has surged by 64% since the previous quarter

The price to sales (P/S) is 27% lower than the last 4 quarters average of 31.6

How efficient is Axonics Modulation Technologies business performance

AXNX's ROS has soared by 95% year-on-year and by 51% since the previous quarter

The ROE has increased by 50% YoY and by 37% from the previous quarter

AXNX's ROA is up by 47% YoY and by 35% from the previous quarter

AXNX's ROIC is up by 23% QoQ but it is down by 20% YoY

What is AXNX's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for AXNX.

How did Axonics Modulation Technologies financials performed over time

The total liabilities has surged by 59% year-on-year and by 6% since the previous quarter

AXNX's quick ratio is down by 25% since the previous quarter but it is up by 12% year-on-year

The company's debt is 89% lower than its equity

AXNX's debt to equity has dropped by 59% year-on-year but it is up by 10% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.